Group 1 - The company reported a sales revenue of 446.69 million yuan for chicken products in April 2025, with a sales volume of 49,800 tons, showing a year-on-year change of 0.44% and 2.15% respectively, while the month-on-month change was -1.48% and -9.81% [2] - In the poultry breeding and processing sector, the sales revenue was 412.95 million yuan with a sales volume of 47,400 tons, reflecting a year-on-year change of 1.44% and 2.43%, and a month-on-month change of -2.53% and -10.67% [2] - The food processing sector achieved a sales revenue of 33.73 million yuan with a sales volume of 2,400 tons, indicating a year-on-year change of -10.37% and -3.05%, while the month-on-month change was 13.42% and 11.54% [2] Group 2 - The company held its 2024 annual general meeting on May 12, 2025, with a total of 187 shareholders present, representing 455,535,404 shares, which is 52.9361% of the total shares [13] - The meeting approved several key resolutions, including the 2024 annual financial report and profit distribution plan, with overwhelming support from shareholders, achieving over 99% approval for most resolutions [20][24][28] - The company plans to participate in an online investor interaction event on May 15, 2025, to discuss its 2024 performance, governance, and future strategies [54]

Core Viewpoint - The legal opinion letter confirms that the 2024 annual general meeting of shareholders for Luoxin Pharmaceutical Group Co., Ltd. was convened and conducted in accordance with relevant laws, regulations, and the company's articles of association [1][2][3]. Group 1: Meeting Procedures - The meeting was convened on May 12, 2025, at the designated location, and the actual time, place, and manner of the meeting were consistent with the prior announcements [4][6]. - The legal opinion asserts that the procedures for convening and holding the meeting complied with legal and regulatory requirements [3][4]. Group 2: Attendance and Qualifications - A total of 170 shareholders attended the meeting, representing 242,426,486 shares, which is 22.8368% of the total voting shares [5][6]. - The qualifications of the attendees, including institutional and individual shareholders, were verified and found to be in compliance with legal requirements [5][6]. Group 3: Voting Procedures and Results - The voting process was conducted through a combination of on-site and online voting, with the results being verified by the legal representatives present [6][8]. - The voting results showed that the majority of proposals were approved, with significant support from shareholders, including 99.8776% approval for one of the key resolutions [8][12].

Group 1 - The annual general meeting of Shanghai Huili Building Materials Co., Ltd. is scheduled for May 12, 2025, at the meeting room on the third floor of No. 406 Hengqiao Road, Pudong New District, Shanghai [1] - The law firm Shanghai Jinmao Law Firm has been appointed to provide legal opinions on the convening, procedures, qualifications of attendees, agenda items, and voting procedures of the meeting [2][3] - The meeting was announced 20 days in advance, complying with relevant laws and regulations [2][3] Group 2 - A total of 93,085,900 shares, representing 51.2869% of the company's total shares, were represented at the meeting [3][4] - The meeting included various agenda items such as the 2024 annual financial budget report and proposals for the appointment of auditors [4] - The voting process was conducted through a combination of on-site and online voting, with results deemed legal and valid according to applicable laws and regulations [5]

北京德恒（深圳）律师事务所 关于广东溢多利生物科技股份有限公司 法律意见 深圳市福田区金田路 4018 号安联大厦 B 座 11 层 电话:0755-88286488 传真:0755-88286499 邮编:518026 北京德恒（深圳）律师事务所 关于广东溢多利生物科技股份有限公司 北京德恒（深圳）律师事务所 关于广东溢多利生物科技股份有限公司 法律意见 德恒 06G20240488-0002 号 致：广东溢多利生物科技股份有限公司 广东溢多利生物科技股份有限公司（以下简称"公司"）2024 年年度股东大会（以 下简称"本次股东大会"）于 2025 年 5 月 12 日（星期一）召开。北京德恒（深圳） 律师事务所（以下简称"德恒"或"本所"）受公司委托，指派浦洪律师、何雪华律 师（以下简称"本所律师"）列席了本次股东大会。根据《中华人民共和国证券法》 （以下简称"《证券法》"）《中华人民共和国公司法》（以下简称"《公司法》"） 《上市公司股东会规则》（以下简称"《股东会规则》"）等法律、行政法规、部门 规章、规范性文件和《广东溢多利生物科技股份有限公司章程》（以下简称"《公司 章程》"）的规定，本所律师就本 ...

证券研究报告 | 行业定期报告 2025 年 05 月 12 日 成长赛道仍具看点，关注股东大会催化 食品饮料行业周报（5.11） 消费品/食品饮料 财报季正式收官，白酒高端与区域龙头平稳落地，25 年行业目标普遍审慎。大 众品表现分化，饮料/零食/宠物食品等成长性赛道仍具看点，啤酒乳制品实现 复苏，调味品相对平淡，龙头业绩更优。本周策略会反馈来看，白酒仍然承 压，大众品 4 月整体动销平稳，乳品/调味品期待 Q2 改善。 核心公司跟踪：短期白酒仍然承压，大众品整体平稳 舍得酒业：Q2 整体需求环比承压明显。舍得主品在宴席场景有双位数增 长，但在商务场景仍相对承压，预计二季度后会有好转，但行业调整期预 计仍将持续。25 年公司在去库存后轻装上阵。 水井坊：Q2 环比压力增加，淡季需求回落明显。25 年将完成井台产品的 迭代，推出 18、28 号产品。终端拓展上，2024 年新增 1 万家门店， 25Q1 新增 2.5 万家，总门店数达到 7-8 万家，根据不同门店情况制定销 售任务。分市场来看，河北增长状况良好，内蒙、山东增速也较快。 伊利股份：Q2 延续改善，奶粉双线驱动。春节动销超预期，Q1 实现正增 长 ...

截至2025年5月9日收盘，野马电池(605378)报收于22.45元，下跌0.66%，换手率1.14%，成交量2.13万 手，成交额4766.8万元。 当日关注点 交易信息汇总 5月9日，野马电池的资金流向情况如下：主力资金净流出101.9万元，占总成交额2.14%；游资资金净流 出110.04万元，占总成交额2.31%；散户资金净流入211.95万元，占总成交额4.45%。 公司公告汇总 浙江野马电池股份有限公司计划于2025年5月19日在浙江省宁波市镇海区骆驼街道荣吉路818号公司会议 室召开2024年年度股东大会。会议将审议以下议案：董事会工作报告、监事会工作报告、财务决算报 告、年度报告及其摘要、利润分配及资本公积金转增股本方案、续聘会计师事务所、修订公司章程和独 立董事述职报告。 2024年，浙江野马电池股份有限公司实现了显著的业绩增长。公司营业收入达到129,864.29万元，同比 增长30.27%；归属于上市公司股东的净利润为15,277.51万元，同比增长44.76%。此外，公司总资产为 162,934.43万元，同比增长3.96%。尽管经营活动产生的现金流量净额为8,070.24万元，较上 ...

北京大成律师事务所 关于九号有限公司 法律意见书 北京大成律师事务所 www.dacheng.com 北京市朝阳区朝阳门南大街 10 号兆泰国际中心 B 座 16-21 层（100020） Chaoyang District, 100020, Beijing, China Tel: +86 10-58137799 Fax: +86 10-58137788 北京大成律师事务所 关于九号有限公司 法律意见书 致：九号有限公司（Ninebot Limited） 北京大成律师事务所（以下简称"本所"）接受九号有限公司（Ninebot Limited， 以下简称"公司"）的委托，指派本所朱旭琦律师、李健律师出席公司 2024 年年 度股东大会（以下简称"本次股东大会"），依据《中华人民共和国证券法》《上 市公司股东会规则》（以下简称"《股东会规则》"）等现行有效的法律、法规、 规范性文件以及公司与存托人中国工商银行股份有限公司（以下简称"存托人"） 于 2020 年 7 月 16 日签署的《九号有限公司存托凭证存托协议》 （以下简称"《存 托协议》"）、《九号有限公司经第三次修订及重述的公司章程大纲细则》（以 下简称" ...

陕西丰瑞律师事务所 关于西安饮食股份有限公司 2024 年年度股东大会的法律意见书 陕西丰瑞律师事务所 SHAANXI FOREVER LAWFIRM 关于西安饮食股份有限公司 2024 年年度股东大会的 法律意见书 【2025】陕丰律（见）字第 0260 号 二〇二五年五月 陕西丰瑞律师事务所 关于西安饮食股份有限公司 2024 年年度股东大会的法 律意见书 TEL:86-29-62625550/51/52/54/55/56/57/58/59 西安市雁翔路 3369 号曲江创意谷 F 座 5-6 层 FAX:86-29-62625555 转 8010 5th&6th floors, Building F,Qujiang Creative Circle, URL:http://www.lawforever.com No.3369 Yan Xiang Road,Xi'an. 关于西安饮食股份有限公司 2024 年年度股东大会的 法律意见书 【2025】陕丰律（见）字第 0260 号 致：西安饮食股份有限公司 陕西丰瑞律师事务所（以下称"本所"）接受西安饮食股份 有限公司（以下简称"公司"或"西安饮食"）委托，指 ...

Core Points - Der Future Science & Technology Holding Group Co., Ltd. is established as a joint-stock company in accordance with relevant Chinese laws and regulations [1][2] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 40 million shares in October 2011 and is listed on the Shenzhen Stock Exchange [1][2] - The registered capital of the company is RMB 797,282,881 [2] Company Overview - The company is located in Suzhou, Jiangsu Province, and focuses on the development and operation of the home furnishing and new materials industries [3] - The business scope includes research, design, production, and sales of smart home products, graphene-related products, and technology development in the fields of internet information technology and e-commerce [3] Share Structure - The company's shares are issued in the form of stocks, with each share having a par value of RMB 1 [4][5] - The total number of shares issued by the company is 797,282,881, all of which are ordinary shares [5] Shareholder Rights and Obligations - Shareholders have rights to dividends, attend and vote at shareholder meetings, supervise company operations, and transfer their shares [8][9] - Shareholders holding more than 5% of shares must report any pledge of their shares to the company [11] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting required to be held within six months after the end of the previous fiscal year [45] - Shareholder meetings must be conducted in accordance with legal and regulatory requirements, and the company must provide necessary facilities for shareholders to participate [46][83] Decision-Making and Voting - Ordinary resolutions require more than half of the voting rights present, while special resolutions require two-thirds [78][80] - Shareholders must disclose any related party transactions and abstain from voting on such matters [82][29]

Group 1 - The company held its sixth board meeting on May 8, 2025, with all seven directors present, and the meeting procedures complied with relevant laws and regulations [2][3] - The board approved the amendment of the company's articles of association, which includes changes to the responsibilities of the actual controller, adjustments to the shareholder meeting procedures, and the introduction of independent director provisions [3][4] - The board proposed to authorize the board or its authorized personnel to handle the filing of the amended articles of association, which requires approval at the 2024 annual general meeting [4][6] Group 2 - The board approved the revision of nine internal control systems, including rules for shareholder meetings and board operations, which also need to be approved at the 2024 annual general meeting [5][6] - The board agreed to convene the 2024 annual general meeting on May 30, 2025, at 2:30 PM in Jiangsu Province [8]